Loading
There are too few genetic counsellors to see every patient who should have an inherited-risk test. Let the cancer team order the test with a short consent script, and use video counsellors for those with results that matter.
Mainstreaming, in which oncologists and nurses consent and order germline testing with genetic counselling reserved for positive or complex results, has been shown in ovarian and breast cancer to increase testing rates and shorten time to result without harm. Combined with a pooled tele-genetics service, it would let genetic counsellors cover a much larger population. The proposal is to make this the default pathway with a national tele-genetics roster.
Shares Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage, Not enough oncologists, nurses, pathologists, physicists, HR-positive / HER2-negative breast cancer, Colorectal cancer.
Shares Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage, Not enough oncologists, nurses, pathologists, physicists.
Shares Inherited risk is mostly unidentified, Not enough oncologists, nurses, pathologists, physicists, Germline (hereditary) testing.
Shares Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage, Not enough oncologists, nurses, pathologists, physicists.
Shares Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage, Not enough oncologists, nurses, pathologists, physicists.
Shares Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage, Not enough oncologists, nurses, pathologists, physicists.
Shares Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage, Not enough oncologists, nurses, pathologists, physicists.
Shares Inherited risk is mostly unidentified, Germline (hereditary) testing, Ovarian cancer.